If big data is to fulfill its potential for advancing the state of modern healthcare, developers of medical AI must be willing to show their work. 

Low-back imaging and interventions are often named among healthcare’s iffiest expenses due to the hit-or-miss predictability of the outcomes.

Shareholders for the Palo Alto, California-based firm recently gave their "overwhelming" approval to the deal. 

Dartmouth College experts are now looking to upload their novel training to the web to help others share in their success. 

President and CEO Ken Song, MD, said the radiopharmaceutical field remains an untapped opportunity in cancer care.

Suzanne Steinbaum, MD, literally wrote the book on eating a heart-healthy diet, and now she has revealed the food she eats each and every day.

In-hospital mortality, myocardial injury and acute kidney injury were all more common when patients with a history of heart failure tested positive for COVID-19. 

Hubris is the fundamental failure of most such endeavors, Stanford imaging experts wrote in JACR. 

The technique identifies individuals with a specific growth factor receptor common in those with non-small cell cancer.

State-specific regulations and licensing are among the top issues impeding remote reading, researchers noted in AJR.